cGxP.wire https://validator.w3.org/feed/docs/rss2.html Lunai Bioworks Expands Parkinson’s AI Drug Discovery Alliance MiNK Therapeutics to Present AgenT-797 Clinical Update Vivani Medical Completes Phase 1 SLIM-1 Dosing of NPM-139 Implant Propanc Biopharma Reports Strong Preclinical PRP Results Annexon Reports Rapid GBS Responses with Tanruprubart in FORWARD Study Vistagen Reports Positive Phase 2 Fasedienol Repeat-Dose Data Ascendis Pharma Shows Positive Long-Term COACH Results Pacira BioSciences Publishes Two-Year Phase 1 PCRX-201 Knee OA Data Medtronic Expands CE Mark for Sphere-9 in Ventricular Ablation WindRose Recapitalizes Verified Clinical Trials to Fuel Growth Theriva Biologics Advances VCN-01 in Pancreatic Cancer Senhwa Wins TFDA Clearance for CX-5461 Immunotherapy Trial BioVie Advances Parkinson’s Program with Phase 2 Success Galibra Neuroscience Wins FDA Designations for SSADH Therapy Agenus Advances Phase 3 ROBBIN Trial for MSS Colon Cancer LifeMine Raises $263M to Advance LIFE-001 Transplant Therapy Phoenix Nest Secures $2.98M to Advance JLK-247 Gene Therapy Merck FDA Accepts ENFLONSIA sBLA for Second RSV Season Vedanta Biosciences Secures $60M to Advance Phase 3 VE303 Olio Labs AI Platform Predicts Human Drug Trial Outcomes Ono Pharma Partners with Mediar to Develop Novel Fibrosis Antibodies CSHL and Northwell Build 150+ Next-Gen Cancer Models Harrow Acquires TYRVAYA Global Rights, Expands Dry Eye Portfolio Kodiak Sciences Advances KSI-101 Phase 3 PEAK Trial Alteogen Signs $365M Global Deal for Hybrozyme Platform Schrödinger and BMS Expand AI-Powered Drug Discovery NIPRO Launches FDA-Cleared ELISIO-HX Dialyzer in U.S. Aveva Clears Patent Appeal for Generic ZTlido Launch BlueWind Medical Wins FDA Clearance for Revi Extend Implant SciSparc Subsidiary NeuroThera Launches Phase IIb Trial of SCI-110 for Tourette Syndrome Leads Biolabs’ Partner Oblenio Bio Doses First Patients in Phase 1a Trial of LBL-051 Leads Biolabs Advances Opamtistomig Phase II Trial in First-Line Liver Cancer Insilico Medicine Nominates AI-Designed ISM9077 as Preclinical Candidate for Ocular Diseases Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine Francis Medical Marks First New York Use of Vanquish System FibroBiologics Secures European Patent for Cartilage Gene Therapy Damora Therapeutics Launches Phase 1 Trial of DMR-001 BriaCell Secures FDA Clearance for Prostate Cancer Therapy NIH Expands Human Cancer Models for Precision Oncology CervoMed Shares Neflamapimod Development Update UCB Reports FINTEPLA Study Showing Sustained LGS Benefits Obsidian Therapeutics Enrolls First Patient in Registration-Enabling Agni-01 Melanoma Trial Novo Nordisk Wins Dutch Injunction Over Semaglutide Spray Summit Therapeutics Launches Global Phase 3 Ivonescimab Trial in Bladder Cancer Apertura and FAST Partner on Angelman Gene Therapy Innovation Lexeo Therapeutics Advances LX2020 with FDA RMAT Designation Eton Expands Infantile Hemangioma Franchise with ASN-001 Acquisition AEYE Health Study Validates AI for Diabetic Eye Screening Takeda Wins FDA Approval for ORZEYFUL in Narcolepsy Type 1 Innovent Advances IBI363 Into Phase III Colorectal Cancer Trial